These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1899177)

  • 21. [Plasminogen activation by antiplasminogen monoclonal antibody IV-1C. Properties and mechanism of reaction].
    Makohonenko IeM; Iakovlev SO; Slomins'kyĭ OIu; Korol'chuk VI; Hrynenko TV; Sokolovs'ka LA; Druzhyna NM; Kolesnykova IM; Chernyshov VI; Sederkhol'm-Vil'iams SA
    Ukr Biokhim Zh (1999); 2000; 72(4-5):99-108. PubMed ID: 11200460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divalent cation-induced changes in conformation of protein kinase C.
    Lester DS; Brumfeld V
    Biophys Chem; 1991 Feb; 39(2):215-24. PubMed ID: 2059668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein(a): a kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator.
    Liu JN; Harpel PC; Pannell R; Gurewich V
    Biochemistry; 1993 Sep; 32(37):9694-700. PubMed ID: 8373773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.
    Swaisgood CM; French EL; Noga C; Simon RH; Ploplis VA
    Am J Pathol; 2000 Jul; 157(1):177-87. PubMed ID: 10880388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the lysine binding sites of human plasminogen in the fibrinogen stimulated rate of active site formation in the streptokinase-plasminogen equimolar complex.
    Smith JH; Morris JP; Chibber BA; Castellino FJ
    Thromb Res; 1984 Jun; 34(6):499-506. PubMed ID: 6429889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stopped-flow fluorescence kinetic studies of Glu-plasminogen. Conformational changes triggered by AH-site ligand binding.
    Christensen U; Mølgaard L
    FEBS Lett; 1991 Jan; 278(2):204-6. PubMed ID: 1991514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of plasminogen activation by monoclonal antibodies to the kringle 5-B chain segment of human plasminogen.
    Church WR; Messier TL
    Hybridoma; 1991 Dec; 10(6):659-72. PubMed ID: 1726159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrin and plasminogen structures essential to stimulation of plasmin formation by tissue-type plasminogen activator.
    Suenson E; Petersen LC
    Biochim Biophys Acta; 1986 Apr; 870(3):510-9. PubMed ID: 2938632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activator.
    Lijnen HR; Van Hoef B; Collen D
    Biochim Biophys Acta; 1986 Dec; 884(3):402-8. PubMed ID: 3778931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of cyanogen-bromide-digested fibrinogen on the kinetics of plasminogen activation by urokinase.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1984 Nov; 144(3):541-4. PubMed ID: 6489341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of plasminogen activation by components of the extracellular matrix.
    Stack S; Gonzalez-Gronow M; Pizzo SV
    Biochemistry; 1990 May; 29(20):4966-70. PubMed ID: 2114170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanisms of the activation of plasminogen by streptokinase and urokinase.
    Takada Y; Takada A
    Adv Exp Med Biol; 1990; 281():223-34. PubMed ID: 2102613
    [No Abstract]   [Full Text] [Related]  

  • 34. Roles of individual kringle domains in the functioning of positive and negative effectors of human plasminogen activation.
    Menhart N; Hoover GJ; McCance SG; Castellino FJ
    Biochemistry; 1995 Feb; 34(5):1482-8. PubMed ID: 7849007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
    Ellis V; Whawell SA; Werner F; Deadman JJ
    Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells.
    Moser TL; Enghild JJ; Pizzo SV; Stack MS
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):867-73. PubMed ID: 7537960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasminogen carbohydrate side chains in receptor binding and enzyme activation: a study of C6 glioma cells and primary cultures of rat hepatocytes.
    Hall SW; VandenBerg SR; Gonias SL
    J Cell Biochem; 1990 Jul; 43(3):213-27. PubMed ID: 1696276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational changes in Mycobacterium smegmatis glutamine synthetase induced by certain divalent cations.
    Matsuoka K; Kimura K
    J Biochem; 1985 Apr; 97(4):1033-42. PubMed ID: 2863260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A concerted structural transition in the plasminogen activator inhibitor-1 mechanism of inhibition.
    Blouse GE; Perron MJ; Thompson JH; Day DE; Link CA; Shore JD
    Biochemistry; 2002 Oct; 41(40):11997-2009. PubMed ID: 12356300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The control of the urokinase-catalyzed activation of human glutamic acid 1-plasminogen by positive and negative effectors.
    Urano T; Sator de Serrano V; Chibber BA; Castellino FJ
    J Biol Chem; 1987 Nov; 262(33):15959-64. PubMed ID: 3680236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.